NME1 Protects Against Neurotoxin-, α-Synuclein- and LRRK2-Induced Neurite Degeneration in Cell Models of Parkinson’s Disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1559-1182
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
NME1 Protects Against Neurotoxin-, α-Synuclein- and LRRK2-Induced Neurite Degeneration in Cell Models of Parkinson’s Disease ; day:8 ; month:10 ; year:2021 ; pages:1-16
Molecular neurobiology ; (8.10.2021), 1-16
- Urheber
-
Anantha, Jayanth
Goulding, Susan R.
Tuboly, Eszter
O’Mahony, Adam G.
Moloney, Gerard M.
Lomansey, Gareth
McCarthy, Cathal M.
Collins, Louise M.
Sullivan, Aideen M.
O’Keeffe, Gerard W.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12035-021-02569-6
- URN
-
urn:nbn:de:101:1-2021122505551889082850
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Anantha, Jayanth
- Goulding, Susan R.
- Tuboly, Eszter
- O’Mahony, Adam G.
- Moloney, Gerard M.
- Lomansey, Gareth
- McCarthy, Cathal M.
- Collins, Louise M.
- Sullivan, Aideen M.
- O’Keeffe, Gerard W.
- SpringerLink (Online service)
Ähnliche Objekte (12)
LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models
LRRK2 contributes to monocyte dysregulation in Parkinson’s disease
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Crystallizing the Parkinson’s disease protein LRRK2 under microgravity conditions
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
Parkinson-causing mutations in LRRK2 impair the physiological tetramerization of endogenous α-synuclein in human neurons
Models of α-synuclein aggregation in Parkinson’s disease
Structural basis for Parkinson’s disease-linked LRRK2’s binding to microtubules
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2
Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models
LRRK2 contributes to monocyte dysregulation in Parkinson’s disease
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Crystallizing the Parkinson’s disease protein LRRK2 under microgravity conditions
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
Parkinson-causing mutations in LRRK2 impair the physiological tetramerization of endogenous α-synuclein in human neurons
Models of α-synuclein aggregation in Parkinson’s disease
Structural basis for Parkinson’s disease-linked LRRK2’s binding to microtubules
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2
Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models
LRRK2 contributes to monocyte dysregulation in Parkinson’s disease
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Crystallizing the Parkinson’s disease protein LRRK2 under microgravity conditions
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
Parkinson-causing mutations in LRRK2 impair the physiological tetramerization of endogenous α-synuclein in human neurons
Models of α-synuclein aggregation in Parkinson’s disease
Structural basis for Parkinson’s disease-linked LRRK2’s binding to microtubules
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2
Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease